Abstract
Epidemiologie studies of the non-Hodgkin’s lymphomas as one entity, while perhaps a useful first step, have obvious limitations. This is particularly true with regard to attempts to identify aetiologic factors. Clearly there are sufficient differences between reticulum cell sarcoma, lymphosarcoma and Hodgkin’s disease to warrant viewing them separately at present. In contrast to Hodgkin’s disease, lymphosarcoma and reticulum cell sarcoma are rarely localised (Rosenberg and Kaplar, 1970) have unpredictable patterns of spread and frequently involve tonsillar tissue and extra nodal sites, including the bone marrow and liver (Peters et al., 1968). This latter observation is particularly true of reticulum cell sarcoma. There is a high frequency of gastrointestinal tract involvement in the non-Hodgkin’s lymphomas of childhood, and the pattern of spread in Hodgkin’s disease seems to be contiguous whereas in these other lymphomas it is non-contiguous. Other important differences relate to complications and response to therapy. Lymphosarcoma is frequently associated with a lymphatic leukaemia stage. This occurs with less frequency with reticulum cell sarcoma and is rare in Hodgkin’s disease (Beutler, 1954; Rosenberg et al., 1961). Nitrogen mustard appears to be more effective in Hodgkin’s disease than with the other lymphomas, which are in general more resistant to therapy (Livingston and Carter, 1970).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aisenberg, A. C. and Bloch, K.: Immunoglobulins on the surface of neoplastic lymphocytes. New Eng. J. Med., 287:272, 1972.
Allen, D. W. and Cole, P.: Viruses and human cancer. New Eng. J. Med., 286:70, 1972.
Anderson, R. E., Ishida, K., Li, Y. et al.: Geographic aspects of malignant lymphoma and multiple myeloma. Amer. Jr. Pathol., 6i: 85, 1970.
Azzopardi, J. G. and Evans, D. J.: Malignant lymphoma of parotid associated with Mikulicz disease (benign lymphoepithelial lesion). J. Clin. Pathol.,24:744, 1971
Bailey, R. J., Burgert, E. D. and Dahlin, D. C.: Malignant lymphoma in children. Pediat., 28; 985, 1961.
Bellanti, J. A.: Suppression of the immune response. In: Immunology 16o ( Philadelphia, London, Toronto: W. B. Saunders Co., 1972 ).
Berard, C. W.: Histopathology of lymphoreticular disorders. In: Hematology, 901 ( W. J. Williams, editor), ( New York: McGraw-Hill, 1972 ).
Berard, C. W. and Dorfman, R. F.: Histopathology of malignant lymphomas. In: Clinics in Hematology, 3 (S. A., Rosenberg, editor), ( London, Philadelphia, Toronto: W. B. Saunders Co, 1974, 39 ).
Beutler, E.: The development of acute myelogenous leukemia in a patient with reticulum cell lymphoma. Ann. Int. Med., 40:1217,1954.
Bouroncle, B. A. Wiseman, B. K. and Doan, C. A.: Leukemic reticuloendotheliosis. Blood, 13: 609, 1958.
Brown, R. C., Schiff, M. and Mitchell, M. S.: Reticulum cell sarcoma of host origin arising in a transplanted kidney. Ann. Int. Med.,80:459, 1974.
Burnet, F. M.: Immunologic aspects of malignant disease. Lancet, 1: 1171, 1967.
Cammarata, R. J., Rodman, G. P. and Jensen, W. N.: Systemic rheumatic disease and malignant lymphoma. Arch. Int. Med.,111:330,1963.
Casey, T. P.: The development of lymphomas in mice with autoimmune disorders treated with azathioprine. Blood, 31: 396, 1968.
Ceglowski, W. S. and Friedman, H.: Immunosuppressive effects of Friend and Rauscher leukemia disease viruses on cellular and humoral antibody formation. J. Nat. Cancer Inst., 40: 983, 1968.
Chime’, H.: Suppression of lymphocyte transformation by aspirin. Lancet,2:861, 5973.
Chin, A. H., Saiki, J. H., Trujillo, J. M. et ai Periferal blood T and B lymphocytes in patients with lymphoma and acute leukemia. Clin. Immunol. Immunopathol.,1:499, 1973.
Churchill, A. E.: Herpes-type virus isoloated in cell culture from tumors of chickens with Marek’s disease: I. studies in cell culture, J. Nat. Cancer Inst., 41939, 1968.
Cox, M. T.: Malignant lymphoma of thyroid. J. Clin. Pathol.,17:591, 5964.
Dmochowski, L.: Current status of the relationship of viruses to leukemia, lymphoma, and solid tumors, in Leukemia-Lymphoma. A collection of papers presented at the,4th. Annual Clinical Conference on Cancer, 1969, at the University of Texas, 37 ( Chicago: Year Book Med. Pub., 597o ).
Doll, R. and Kinlen, L.: Immunosurveillance and cancer: epidemiological evidence. Brit. Med.,4 :4 20, 1970.
Dorn, C. R., Taylor, D. O. N. and Gibbard, H. H.: Epizoetiologic characteristics of canine and feline leukemia and lymphoma. Amer. J. Vet. Res., 28:993, 1967.
Edelman, S., Parkins, R. A. and Rubin, C. E.: Abdominal lymphoma presenting as malabsorption. Medicine, 45: i s I, 1966.
Fialkow, P. J.: Hypothesis: `Immunologic oncogenesis’. Blood, 3o:388, 1967.
Froland, S. S., Natvig, J. B. and Stavem, P.: Immunologic characterization of lymphocytes in lymphoproliferative disorders. Restriction of classes, subclasses and allotypes of membrane-bound Ig. Scand.J. Immunol., i: 351, 1972.
Gall, E. A. and Rappaport, H.: Seminar on diseases of lymph nodes and spleen. In: Proceedings of the 23rd Seminar of the American Society of Clinical Pathology, 1 (J. R., MacDonald, editor) ( Amer. Soc. Clin. Pathol., 1951 ).
Gams, R. A., Neal, J. A. and Conrad, F. G.: Hydantoin induced pseudo-lymphoma. Ann. Int. Med., 69:557, 1968.
Gergely, P., Szegedi, G., Berenyl, E. et al Lymphocyte surface immunoglobulins in Hodgkin’s disease. New Eng. J. Med.,289:220, 1973
Grundy, G. W., E. T., E. T. and Fraumeni, J. F.: Non-Hodgkin’s lymphoma in childhood: epidemiologic features. y. Nat. Cancer Inst.,5z: 767, 1973.
Hargraves, M. M.; Leukemia and the G.P. y. Arkansas Med. Soc., 58:522,1962.
Harris, O. D., Cooke, W. T., Thompson, H. et al Malignancy in adult celiac disease and idiopathic steatorrhoea. Amer. y. Med.,42:899, 1967.
Hays, E. F.: Graft-versus-host reactions and the viral induction of mouse lymphoma. Cancer Res., 32: 270, 1972.
Hirsch, M. S., Phillips, S. M., Solnick, C. et al Activation of leukemia virus by graft-versus-host and mixed lymphocyte reactions in vitro. Proceedings of the National Acad. of Sci. of the USA, 69:5069 5972.
Hoover, R. and Fraumeni, J. F.: Risk of cancer in renal transplant recipients. Lancet,2:55, 1973.
Hyman, G. and Sommers, S.: The development of Hodgkin’s disease and other lymphomas during anticonvulsant therapy. Blood, 28: 456, 1966.
Jarrett, W., Jarrett, O., Lindsay, M. et al., Horizontal transmission of leukemia virus and leukemia in the cat.,. Nat. Cancer Inst.,51:833, 5973.
Jeong, Y. G., Jung, Y. and River, G. L.: Pure RBC aplasia and diphenylhydantoin. J.A.M.A.,229:314, 5974.
Lancet,Editiorial: Is phenytoin carcinogenic? 2:1071, 1971.
Li, F. Fraumeni, J. F., Mantel, N. et al.: Cancer mortality among chemists. Y. Nat. Cancer Inst., 43: 1159, 1969.
Livingstone, R. B. and Carter, S. K.: Single Agents in Cancer Chemotherapy, I ( New York: Plenum Publishing Corp, 1970 ).
MacMahon, B Epidemiology of Hodgkin’s disease. Cancer Res.,26:1189, 1966.
Morgenfeld, M. C.: Toxoplasmosis. Medicina,34:48, 1974.
Pasqualini, C. D. and Caparo, A. C.: Zoonosis and its possible relation with lymphoma and leukemia in man. Medicina,34:i, 1974.
Peters, M. V., Hasselback, R. and Brown, T. C.: The natural history of the lymphomas related to clinical classification. In: Proceedings of the International Conference on Leukemia-Lymphoma, 357 ( C. J. D. Zarafonetis, editor) ( Philadelphia: Lea and Febiger, 1968 ).
Pietra, G., Spencer, K. and Shubik, P.: Response of newly born mice to a chemical carcinogen. Nature, (London), 183:1689,1959.
Prehn, R. T.: The immune reaction as a stimulator of tumor growth. Science, 176:170, 1972.
Prehn, R. and Lappe, M. A.: An immunostimulation theory of tumor develoment. Transplant Rev., 7: 26, 1971.
Ramot, B. and Many, A.: Primary intestinal lymphoma: clinical manifestations and possible effect of environmental factors. In: Current Problems in the Epidemiology of Cancer and Lymphomas, 193 ( E. Grundmann and H. Tullinius, editors) ( Berlin, Heidelberg, New York: Springer-Verlag, 1972 ).
Rappaport, H.: The histologic aspects of lymphoreticular neoplasms. In: Symposium on Lymphoreticular Tumors in Africa, 174 ( F. C. Roulet, editor) ( Basel, New York: S. Karger, 1964 ).
Rosenberg, S. A., Diamond, H. D. and Craver, L. F.: Lymphosarcoma: the effect of therapy and survival in 1,269 patients in a review of 3o years experience. Medicine, 40:31, 1961.
Rosenberg, S. A., Diamond, H. D. and Dargeon, H. W.: Lymphosarcoma in childhood. New Eng.J. Med., 259:5105,1958.
Rosenberg, S. A. and Kaplan, H. S.: Hodgkin’s disease and other malignant lymphomas. Calif. Med., 113:1970.
Rosenlof, R. C., Lemon, H. M. and Rigby, P. G.: Familial factors relating to prognosis of leukemia and lymphoma. National Cancer Institute Monograph, 34:283, 1971.
Saltzstein, S. L.: Lymphoma or drug reaction occurring during hydantoin therapy for epilepsy. Amer. y. Med., 32: 286, 1962.
Saltzstein, S. L. and Ackerman, L. V.: Lymphadenopathy induced by anti-convulsant drugs and mimicking clinically and pathologically malignant lymphomas. Cancer, 12:164, 1959.
Schwartz, R. S. and Beldotti, L:. Malignant lymphomas following allogenic disease: Transition from an immunologic to a neoplastic disorder. Science, 149:1511, 1965.
Scott, R. B. and Robb-Smith, A. H. T.: Histiocytic medullary reticulosis. Lancet,2:194, 1939.
Seligmann, M., Danon, F. and Hurez, D.: Alpha chain disease: a new immunoglobin abnormality. Science, 162:1396, 1968.
Seligmann, M., Preud Homme, J. L. and Broulet, J. C.: B and T cell markers in human proliferative blood diseases and primary immunodeficiencies with special reference to membrane bound immunoglobulins. Transpl. Rev’16:85,1973.
Smith, J. L.: Characterization of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin. Lancet,1:74, 1973.
Talai, N., Asofsky and Lightbudy, P.: Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren’s syndrome. J. Clin. Invest., 49:49,1970.
Talai, N. and Bunin, J. J.: The development of malignant lymphoma in the course of Sjögren’s syndrome. Amer. J. Med., 36: 529, 1964.
Talai, N., Sokolov, L. and Bath, W. F.: Extra salivary lymphoid abnormalities in Sjögren’s syndrome. Amer. J. Med., 43:50, 1967.
Wedderburn, N. and Salaman, M. H.: The immunodepressive effect of Friend virus. II. Reduction of splenic hemolysin-producing cells in primary and secondary responses. Immunology, x5: 439, 1968.
Williams, R. C.: Dermato-myositis and malignancy: a review of the literature. Ann. Int. Med.,5101:111174, 1959.
Winkelstein, A., Mikulla, J. M., Sartiano et al Cellular immunity in Hodgkin’s disease: comparison of cutaneous reactivity and lymphoproliferative response to phytohemagglutinin. Cancer,34:549 1974.
Wood, S. E., Campbell, J. B., Anderson, J. M. et al Lymphocyte response after radiotherapy. Lancet,1:863, 1974.
Young, R. C., Corder, M. P., Haynes, H. A. et al.: Delayed hypersensitivity in Hodgkin’s disease. Amer. J. Med., 52:63, 1972.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1975 N. J. Vianna
About this chapter
Cite this chapter
Vianna, N.J. (1975). Other lymphomas. In: Lymphoreticular Malignancies. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-8053-5_4
Download citation
DOI: https://doi.org/10.1007/978-94-011-8053-5_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-8055-9
Online ISBN: 978-94-011-8053-5
eBook Packages: Springer Book Archive